HR Execs on the Move

BPR Health International

www.bprhealth.com

 
BPR Health International is a Moraga, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
  • Number of Employees: 25-100
  • Annual Revenue: $10-50 Million

Executives

Name Title Contact Details

Similar Companies

Cayuga Medical Center

Cayuga Medical Center is a 204-bed, state-of-the art regional medical center. The Medical Center’s mission is to deliver the highest quality health care and is affiliated with many prestigious health care organizations including Cornell University's Weill Medical College in New York City, Roswell Park Cancer Institute in Buffalo, NY, Rochester General Hospital’s Heart Institute and the Mayo Medical Laboratories. CMC received a silver award for “The Center Is You” campaign that rolled out in 2008.  

Desktop Health

Desktop Health is a leading global provider of professional-grade 3D printing solutions. Our company invents, develops, manufactures and sells 3D printers and proprietary materials worldwide.

Stratum Health System

Stratum Health System is a nonprofit, integrated network providing care and support to people facing chronic or advanced illness. The Stratum family of companies helps patients live as comfortably and meaningfully as possible and offers assistance to their families and caregivers along the way. As their illness advances, Stratum offers a layer of medical and emotional support services that provides compassionate care across the continuum.

UltraRAD Corp

UltraRAD Corp is a West Berlin, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Dimension Therapeutics

Dimension Therapeutics, Inc. is a rare disease company focused on discovering and developing new therapeutic products for people living with devastating rare diseases associated with the liver and based on the most advanced adeno-associated virus (AAV) delivery technology. The company is advancing multiple programs toward clinical development, including: programs addressing unmet needs for patients suffering from OTC deficiency and GSDIa; a collaboration with Bayer HealthCare in hemophilia A, and a wholly owned program in hemophilia B, which is expected to enter clinical testing in the second half of 2015. Dimension has preferred access to multiple AAV vectors from REGENXBIO. The Dimension team and senior advisors include biotech industry veterans and renowned thought leaders in gene therapy and rare diseases.